Provided by NZX
  • FPH6.6


  • Open 6.3 High 6.7 Low 6.51 Bid Price 6.55

    Offer Price 6.6 Value 27979897.53 Volume 4225918

Current as of 29/05/15 07:40PM NZST

Jamie Gray

Jamie Gray is a business reporter for the New Zealand Herald and NZME. news service.

F & P Healthcare tips better profits

F&P Healthcare says profit for the year to March should be around $75m.  Photo / Supplied
F&P Healthcare says profit for the year to March should be around $75m. Photo / Supplied

Fisher & Paykel Healthcare said it had revised up its net profit forecast for the year to March, based on improved sales, despite the ongoing strength of the New Zealand dollar.

The company now expects its net profit to be about $75 million for the year, up from a previous forecast - issued last November - of $69m to $72m.

The revised forecast assumes that the exchange rate will remain at current levels until the end of the financial year.

Fisher & Paykel Healthcare, which specialises in making electronic respiratory devices for the treatment of obstructive sleep apnea (OSA), said sales growth during the second half had been encouraging, particularly for its respiratory consumables products.

"We are expecting constant currency operating revenue growth for the second half to increase to approximately 14 per cent, up from 8 per cent, for the first half," it said in a statement.

Chief executive Michael Daniell said operating margin had also continued to improve as a result of new products and operating efficiency gains.

The company also announced an expansion of its full face mask offering, with the introduction of the "F&P Simplus" - a full face mask for use in the treatment of OSA.

Fisher and Paykel Healthcare shares last traded at $2.45, up 11c or 4.7 per cent from Tuesday's close, and towards the top end of its $1.86 to $2.64 range over the last 52 weeks.


© Copyright 2015, NZME. Publishing Limited

Assembled by: (static) on production apcf02 at 30 May 2015 03:02:21 Processing Time: 250ms